Showing results (111-120 of 282) with videos related to

Sort By:
Pageof 29
Haematologica|June 20, 2015
Ruxolitinib in combination with lenalidomide as therapy for patients with myelofibrosisNaval Daver, Jorge Cortes, Kate Newberry, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 1, 2010
Feasibility of therapy with hypomethylating agents in patients with renal insufficiencyG Nicolas Batty, Hagop Kantarjian, Jean-Pierre Issa, et al.
Blood|July 30, 2010
Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemiaHagop Kantarjian, Farhad Ravandi, Susan O'Brien, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 4, 2016
Patient Characteristics and Outcomes in Adolescents and Young Adults (AYA) With Acute Myeloid Leukemia (AML)Naveen Pemmaraju, Hagop Kantarjian, Farhad Ravandi, et al.
Cancer|October 25, 2011
Prognostic significance of alterations in IDH enzyme isoforms in patients with AML treated with high-dose cytarabine and idarubicinFarhad Ravandi, Keyur Patel, Rajyalakshmi Luthra, et al.
Cancer|October 14, 2004
Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemiaHagop Kantarjian, Deborah Thomas, Susan O'Brien, et al.
Blood|April 27, 2013
Early responses predict better outcomes in patients with newly diagnosed chronic myeloid leukemia: results with four tyrosine kinase inhibitor modalitiesPreetesh Jain, Hagop Kantarjian, Aziz Nazha, et al.
British Journal of Haematology|February 25, 2012
Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndromeTapan M Kadia, Gautam Borthakur, Guillermo Garcia-Manero, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 15, 2013
Effect of NPM1 and FLT3 mutations on the outcomes of elderly patients with acute myeloid leukemia receiving standard chemotherapyNaval Daver, Theresa Liu Dumlao, Farhad Ravandi, et al.
American Journal of Hematology|May 29, 2015
Characteristics, clinical outcome, and prognostic significance of IDH mutations in AMLCourtney D DiNardo, Farhad Ravandi, Sam Agresta, et al.
Pageof 29